|
Annual Report 2003 |
1.59 MB |
|
Key Figures |
74.08 KB |
|
Management Board |
75.29 KB |
|
Letter to the Shareholders |
46.64 KB |
|
Market & Strategy |
98.99 KB |
|
Magazine: Clinical Development of Antibodies |
508.08 KB |
|
Own Product Development |
137.59 KB |
|
Interview with Prof. Dr. Boehncke |
63.51 KB |
|
Research & Development |
110.29 KB |
|
Corporate Governance |
58.62 KB |
|
The MorphoSys Share |
65.93 KB |
|
Management Report |
159.47 KB |
|
Financial Statements |
173.08 KB |
|
Independent Auditor’s Report |
25.88 KB |
|
Balance Sheet and Profit & Loss Statement According to German GAAP |
44.58 KB |
|
Declaration of Corporate Governance Code |
29.66 KB |
|
Supervisory Board Report |
36.06 KB |
|
Supervisory Board |
81.66 KB |
|
Credo |
176.28 KB |
